| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029512 |
| Receipt No. | R000033723 |
| Scientific Title | The change of intraocular pressure after intravitreous injection for retinopathy of prematurity |
| Date of disclosure of the study information | 2017/10/15 |
| Last modified on | 2019/04/05 (Ver. 5) |
| Basic information | ||
| Public title | The change of intraocular pressure after intravitreous injection for retinopathy of prematurity | |
| Acronym | Intraocular pressure after intravitreous injection for retinopathy of prematurity | |
| Scientific Title | The change of intraocular pressure after intravitreous injection for retinopathy of prematurity | |
| Scientific Title:Acronym | Intraocular pressure after intravitreous injection for retinopathy of prematurity | |
| Region |
|
|
| Condition | ||
| Condition | Retinopathy of prematurity | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the change of intraocular pressure after intravitreous injection for retinopathy of prematurity |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Intraocular pressures at 1 minutes after intravitreous injection |
| Key secondary outcomes | Intra ocular pressures of 3, 10, 30, 60 minutes and 1day after intravitreous injection.
Preoperative risk factors for intraocular pressure increasing. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intraocular pressure is measured at pre injection, 1, 3, 10, 30, 60 minutes and 1day after injection.
Axial length, depth of anterior chamber, thickness of lens, thickness of cornea are measured at pre injection. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with retinopathy of prematurity requiring intravitreal injection.
2) Those who can obtain agreement about this research participation by parents. |
|||
| Key exclusion criteria | None | |||
| Target sample size | 25 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Shiga University of Medical Scinece | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | |||||||
| Address | Seta Tsukinowacho, Otsu, Shiga, JAPAN | ||||||
| TEL | 0775482276 | ||||||
| higashi@belle.shiga-med.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Shiga University of Medical Scinece | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | |||||||
| Address | Seta Tsukinowacho, Otsu, Shiga, JAPAN | ||||||
| TEL | 0775482276 | ||||||
| Homepage URL | |||||||
| obata326@belle.shiga-med.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Ophthalmology, Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033723 |